# THERAPIX BIOSCIENCES LTD (TRPXY)

> Institutional ownership reported to the SEC as of Q2 2020, from Form 13F filings. Source: https://holderbook.com/stocks/TRPXY/

- Reporting holders: 4
- Reported value: $312.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $271.0K | 436,189 | 0.0% | 11 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $26.0K | 41,428 | 0.0% | 4 |
| [MILLENNIUM MANAGEMENT LLC](https://holderbook.com/funds/1273087-millennium-management-llc/) | $9.0K | 14,200 | 0.0% | 1 |
| [ENVESTNET ASSET MANAGEMENT INC](https://holderbook.com/funds/1407543-envestnet-asset-management-inc/) | $6.0K | 10,018 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2020 | 4 | $312.0K |
| Q1 2020 | 3 | $11.0K |
| Q4 2019 | 4 | $20.0K |
| Q3 2019 | 4 | $8.5K |
| Q2 2019 | 2 | $26.5K |
| Q1 2019 | 4 | $332.6K |
| Q4 2018 | 4 | $212.0K |